Company Profile
Edwards Lifesciences Stock Price, News & Analysis
- Ticker:
- EW
- Exchange:
- NYSE
- Sector:
- Biopharma
- Location:
- United States
Stock performance
89.32 USD (+0.39%)
Close
Last updated: August 6, 2026
50.5B USD
Market cap
Why the stock is moving
As of Aug 6, 2026, EW closed up 0.39% at $89.32. No new same-company headline was identified in the current news window.
Company overview
Business overview
Edwards Lifesciences is a medical technology company best known for transcatheter heart valve therapies and critical care monitoring. The business is centered on structural heart innovation and procedure adoption.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NYSE, Edwards is a global medtech company with strong exposure to cardiovascular procedures. It sits outside biotech and closer to high-end medical devices.
Business Model Characteristics
The company generates revenue through transcatheter valve systems, monitoring technologies, and related procedure-based products. Investors focus on procedure growth, product expansion, and how well the company can keep widening adoption in structural heart care.
Position Within the Biotechnology Landscape
Edwards is not biotech proper, but it occupies a premium position in healthcare innovation. It tends to move on device adoption and clinical uptake rather than on drug approvals or pipeline readouts.
Future catalysts
Edwards Lifesciences is likely to be driven by TAVR demand, EVOQUE adoption in tricuspid therapy, and continued SAPIEN franchise strength. The key question is whether the update shows enough repeatable demand to look like a durable revenue driver rather than a one-quarter bump. If adoption broadens, sentiment can improve faster than the reported numbers alone would suggest.
Recent news
- 01
- 02
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Edwards Lifesciences (EW)?
Edwards Lifesciences (EW) most recently closed at 89.32 USD, a +0.39% move versus the previous session.
What is the market cap of Edwards Lifesciences (EW)?
Edwards Lifesciences currently has a market capitalization of 50.5B USD on BioPharmSignal.
What does Edwards Lifesciences do?
Edwards Lifesciences is a medical technology company best known for transcatheter heart valve therapies and critical care monitoring. The business is centered on structural heart innovation and procedure adoption.
On which exchange is EW stock listed?
Edwards Lifesciences (EW) is associated with NYSE, United States, Biopharma.
What is Edwards?
Edwards Lifesciences is likely to be driven by TAVR demand, EVOQUE adoption in tricuspid therapy, and continued SAPIEN franchise strength.
Which conditions is Edwards Lifesciences targeting with Edwards?
Edwards Lifesciences is likely to be driven by TAVR demand, EVOQUE adoption in tricuspid therapy, and continued SAPIEN franchise strength.
How does Edwards Lifesciences describe recent progress with Edwards?
Edwards Lifesciences is likely to be driven by TAVR demand, EVOQUE adoption in tricuspid therapy, and continued SAPIEN franchise strength.
What is Lifesciences?
Edwards Lifesciences is a medical technology company best known for transcatheter heart valve therapies and critical care monitoring.